Hikma Pharmaceuticals (HIK)

Sector:

Pharma and Biotech

1,636.00p

Questor : Hikma Pharmaceuticals	13-Mar-2014	Telegraph
Investment Column:Hikma	02-Feb-2011	The Independent
Questor:Hikma Pharmaceuticals	23-Jul-2008	Telegraph
Market Report: Respite for Rentokil after buyout...	18-Jan-2008	The Independent
Property sector buoyed by Laxey's £1bn opportuni...	15-Jan-2008	Telegraph
Avis Europe hits the buffers after downgrade	06-Sep-2007	The Independent
Questor: Hikma Pharma	06-Sep-2007	Telegraph
Equities go into reverse as Dow slides on poor h...	06-Sep-2007	Telegraph
Mortgage banks and housebuilders knock Footsie	28-Jun-2007	Guardian
Clothing feels a chill from bad weather and risi...	28-Jun-2007	Telegraph
Traders seek safety in pharmaceutical stocks	28-Jun-2007	The Independent
The Investment Column: Hikma Pharmaceuticals	28-Jun-2007	The Independent
The Investment Column: Hikma Pharmaceuticals	23-Mar-2007	The Independent
The Week Ahead: Wolseley investors seek calm ami...	19-Mar-2007	The Independent
Online gaming takes a hit	23-Jan-2007	Guardian
Market Report: Akzo Nobel heads the quest to tak...	20-Jan-2007	The Independent
Mining stocks prop up the FTSE	19-Jan-2007	Guardian
This Week's Market Movers	17-Nov-2006	Motley Fool UK
This Week's Market Movers	06-Nov-2006	Motley Fool UK
Analysts downbeat on BSkyB	03-Nov-2006	Guardian

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Compare performance with the sector and the market.

Key:

Value

Price Trend

Income

Growth

CEO	Said Darwazah
Chair	Victoria Hull